Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current Assets:
Cash and cash equivalents	$ 5,950	$ 55,428
Total Current Assets	5,950	55,428
Investments, net of impairment of $500,000 and $500,000
Total Assets	5,950	55,428
Current Liabilities:
Accounts payable	10,219	16,312
Notes Payable	1,387,694	1,387,694
Notes Payable, accrued interest	1,067,644	866,226
Notes Payable, related party and accrued interest	181,490	166,251
Total Liabilities	2,647,047	2,436,483
Commitments and Contingencies
Stockholders’ Equity (Deficit):
Preferred stock; $0.01 par value, 25,000,000 authorized shares;20,500,000 shares designated as Series B Convertible Preferred Stock; Series B Convertible Preferred shares 6,196,893 issued and outstanding	61,969	61,969
Common stock; $0.01 par value; 150,000,000 authorized; 78,696,461shares issued and outstanding	786,964	786,964
Stock to be issued	8,600	8,600
Additional paid-in capital	48,876,398	48,876,398
Accumulated deficit	(52,375,028)	(52,114,986)
Total Stockholders’ Equity (Deficit)	(2,641,097)	(2,381,055)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 5,950	$ 55,428